Bio Usawa, a biotech firm focused on expanding access to biologic medicines in Africa, has appointed Dr. Aida Habtezion, former Chief Medical Officer at Pfizer, to its Board of Directors. Her expertise in global medical leadership and innovation will support Bio Usawa's mission to build sustainable biotechnology manufacturing on the continent and improve patient access to advanced therapies. This strategic move aims to enhance health security and foster scientific and industrial development in Africa. Dr. Habtezion's appointment strengthens Bio Usawa's governance as it advances its vision for equitable healthcare in the region.
Red Cat Holdings shares increased by 4.83% in premarket trading following the launch of Hellcat, a new small unmanned aircraft system designed for versatile mission needs. Built on a modular platform, Hellcat supports customizable command, payloads, ...
Skanska has secured a SEK 4.4 billion contract to construct a new emergency hospital building at Karlstad Central Hospital in Sweden. The high-tech, seven-story building will cover approximately 90,000 square meters and include an emergency departmen...
High Tide Inc. has obtained credit approval for C$40 million in senior secured credit facilities from Bank of Montreal. The new loan agreement includes a $25 million revolving facility and a $15 million delayed draw term loan, which will refinance ex...
Gilat Satellite Networks announced it will acquire Comtech Telecommunications' Satellite & Space Communications segment for $157.5 million in cash. This acquisition will create a company with projected annual revenue exceeding $700 million, more than...
Tower Semiconductor announced a multi-year agreement with IQE plc to supply Indium Phosphide (InP) epiwafers, enhancing its silicon photonics capabilities crucial for AI-driven data centers. This deal includes minimum purchase commitments and recipro...
